Oramed Pharmaceuticals Inc

The current institutional shareholding score of Oramed Pharmaceuticals Inc is 3.00, ranking 192 out of 387 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 28.15%, representing a quarter-over-quarter increase of 21.30%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.36% of shares outstanding, with 0.25% decrease in holdings.